These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 19563794
1. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer. Schmid RW, Lotz J, Schweigert R, Lackner K, Aimo G, Friese J, Rosiere T, Dickson D, Kenney D, Maine GT. Clin Biochem; 2009 Oct; 42(15):1543-8. PubMed ID: 19563794 [Abstract] [Full Text] [Related]
17. Evaluation of a microparticle enzyme immunoassay for the measurement of sirolimus in whole blood (Abbott IMx sirolimus). Scholer A, Von Rickenbach R, Faffa G, Vetter B. Clin Lab; 2006 Dec; 52(7-8):325-34. PubMed ID: 16955630 [Abstract] [Full Text] [Related]
18. [Hepatitis C virus screening: performances characteristics of a commercial automated chemiluminescent microparticle immunoassay (CMIA-ARCHITECT anti-HCV)]. Petitjean Lecherbonnier J, Gouarin S, Dina J, Vabret A, Freymuth F. Pathol Biol (Paris); 2007 Dec; 55(10):512-20. PubMed ID: 17959324 [Abstract] [Full Text] [Related]
19. High-performance liquid chromatography versus immunoassay for the measurement of sirolimus: comparison of two methods. Zochowska D, Bartłomiejczyk I, Kamińska A, Senatorski G, Paczek L. Transplant Proc; 2006 Dec; 38(1):78-80. PubMed ID: 16504669 [Abstract] [Full Text] [Related]
20. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Koster RA, Dijkers EC, Uges DR. Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]